Sumoylation pathway as potential therapeutic targets in cancer

L. Gong, R. Qi, D. W.C. Li

Research output: Contribution to journalReview article

8 Citations (Scopus)

Abstract

Sumoylation is a covalent protein posttranslational modification that conjugates the small ubiquitin-like peptide SUMO to substrate. Sumoylation is critically implicated in multiple biological processes, including cell proliferation, differentiation, senescence and apoptosis, etc. Therefore, it is not surprising that dysregulation of sumoylation has been implicated in tumorigenesis and different types of cancer were found to be addicted to functional sumoylation pathway. The potential role for sumoylation as a therapeutic target in caner is emerging. In this review, we summarize current knowledge regarding the involvement of sumoylation in genome stability and DNA damage response. We will further discuss the therapeutic potential of sumoylation as synthetic lethal partner and as a key signaling pathway in cancer stem cells.

Original languageEnglish (US)
Pages (from-to)900-905
Number of pages6
JournalCurrent Molecular Medicine
Volume16
Issue number10
DOIs
StatePublished - Dec 1 2016

Fingerprint

Sumoylation
Cell proliferation
Ubiquitin
Stem cells
Genes
Apoptosis
Peptides
DNA
Substrates
Neoplasms
Proteins
Therapeutics
Biological Phenomena
Neoplastic Stem Cells
Genomic Instability
Post Translational Protein Processing
DNA Damage
Cell Differentiation
Carcinogenesis
Cell Proliferation

Keywords

  • Cancer stem cell
  • DNA damage response
  • Genome stability
  • Sumoylation
  • Synthetic lethality

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology

Cite this

Sumoylation pathway as potential therapeutic targets in cancer. / Gong, L.; Qi, R.; Li, D. W.C.

In: Current Molecular Medicine, Vol. 16, No. 10, 01.12.2016, p. 900-905.

Research output: Contribution to journalReview article

Gong, L. ; Qi, R. ; Li, D. W.C. / Sumoylation pathway as potential therapeutic targets in cancer. In: Current Molecular Medicine. 2016 ; Vol. 16, No. 10. pp. 900-905.
@article{ac0b326048534b119216f0415f7702af,
title = "Sumoylation pathway as potential therapeutic targets in cancer",
abstract = "Sumoylation is a covalent protein posttranslational modification that conjugates the small ubiquitin-like peptide SUMO to substrate. Sumoylation is critically implicated in multiple biological processes, including cell proliferation, differentiation, senescence and apoptosis, etc. Therefore, it is not surprising that dysregulation of sumoylation has been implicated in tumorigenesis and different types of cancer were found to be addicted to functional sumoylation pathway. The potential role for sumoylation as a therapeutic target in caner is emerging. In this review, we summarize current knowledge regarding the involvement of sumoylation in genome stability and DNA damage response. We will further discuss the therapeutic potential of sumoylation as synthetic lethal partner and as a key signaling pathway in cancer stem cells.",
keywords = "Cancer stem cell, DNA damage response, Genome stability, Sumoylation, Synthetic lethality",
author = "L. Gong and R. Qi and Li, {D. W.C.}",
year = "2016",
month = "12",
day = "1",
doi = "10.2174/1566524016666161223105201",
language = "English (US)",
volume = "16",
pages = "900--905",
journal = "Current Molecular Medicine",
issn = "1566-5240",
publisher = "Bentham Science Publishers B.V.",
number = "10",

}

TY - JOUR

T1 - Sumoylation pathway as potential therapeutic targets in cancer

AU - Gong, L.

AU - Qi, R.

AU - Li, D. W.C.

PY - 2016/12/1

Y1 - 2016/12/1

N2 - Sumoylation is a covalent protein posttranslational modification that conjugates the small ubiquitin-like peptide SUMO to substrate. Sumoylation is critically implicated in multiple biological processes, including cell proliferation, differentiation, senescence and apoptosis, etc. Therefore, it is not surprising that dysregulation of sumoylation has been implicated in tumorigenesis and different types of cancer were found to be addicted to functional sumoylation pathway. The potential role for sumoylation as a therapeutic target in caner is emerging. In this review, we summarize current knowledge regarding the involvement of sumoylation in genome stability and DNA damage response. We will further discuss the therapeutic potential of sumoylation as synthetic lethal partner and as a key signaling pathway in cancer stem cells.

AB - Sumoylation is a covalent protein posttranslational modification that conjugates the small ubiquitin-like peptide SUMO to substrate. Sumoylation is critically implicated in multiple biological processes, including cell proliferation, differentiation, senescence and apoptosis, etc. Therefore, it is not surprising that dysregulation of sumoylation has been implicated in tumorigenesis and different types of cancer were found to be addicted to functional sumoylation pathway. The potential role for sumoylation as a therapeutic target in caner is emerging. In this review, we summarize current knowledge regarding the involvement of sumoylation in genome stability and DNA damage response. We will further discuss the therapeutic potential of sumoylation as synthetic lethal partner and as a key signaling pathway in cancer stem cells.

KW - Cancer stem cell

KW - DNA damage response

KW - Genome stability

KW - Sumoylation

KW - Synthetic lethality

UR - http://www.scopus.com/inward/record.url?scp=85013895895&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85013895895&partnerID=8YFLogxK

U2 - 10.2174/1566524016666161223105201

DO - 10.2174/1566524016666161223105201

M3 - Review article

C2 - 28017138

AN - SCOPUS:85013895895

VL - 16

SP - 900

EP - 905

JO - Current Molecular Medicine

JF - Current Molecular Medicine

SN - 1566-5240

IS - 10

ER -